Figure 1 | Scientific Reports

Figure 1

From: KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway

Figure 1

Expression of KIF2C in NSCLC cell lines. (a) KIF2C expression is significantly high-expressed in NSCLC cell lines; (b,c) KIF2C expression was increased in human lung adenocarcinoma(LUAD) and human lung squamous cell carcinoma(LUSC) tissues; (d,e) High KIF2C expression in human lung adenocarcinoma(LUAD) and human lung squamous cell carcinoma(LUSC) tissues were associated with worse prognosis (*P < 0.05, **P < 0.01, and ***P < 0.001).

Back to article page